Data safety monitoring boards and other study methodologies that address subject safety in "high-risk" therapeutic trials in youths

J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):489-492. doi: 10.1097/chi.0b013e31802f5f54.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adolescent
  • Child
  • Clinical Trials Data Monitoring Committees*
  • Clinical Trials as Topic*
  • Cyclohexanols / therapeutic use*
  • Delayed-Action Preparations
  • Depressive Disorder, Major / drug therapy*
  • Drug-Related Side Effects and Adverse Reactions*
  • Endpoint Determination / adverse effects*
  • Female
  • Human Experimentation*
  • Humans
  • Male
  • Research Design*
  • Risk Factors
  • Selective Serotonin Reuptake Inhibitors / therapeutic use*
  • Suicide, Attempted
  • Treatment Outcome
  • Venlafaxine Hydrochloride

Substances

  • Cyclohexanols
  • Delayed-Action Preparations
  • Serotonin Uptake Inhibitors
  • Venlafaxine Hydrochloride